Zai Lab (ZLAB) Equity Income (2020 - 2022)

Zai Lab's (ZLAB) quarterly Equity Income came in at -$221000.0 in Q1 2022, down 213.33% year-on-year from $195000.0 in Q1 2021, and up 56.58% quarter-over-quarter from -$509000.0 in Q4 2021.

Zai Lab (ZLAB) Equity Income (2020 - 2022) Analysis & Trends

Zai Lab has disclosed Equity Income across 3 years of filings, most recently posting -$221000.0 for Q1 2022.

  • Equity Income for Q1 2022 came in at -$221000.0, down 213.33% year-over-year; the trailing twelve-month figure through Dec 2022 was -$221000.0 (up 79.09% YoY), and the FY2022 annual result was -$221000.0, up 79.09% from the prior year.
  • Equity Income came in at -$221000.0 for Q1 2022 at Zai Lab, up from -$509000.0 in the prior quarter.
  • In the past five years, Equity Income ranged from a high of $195000.0 in Q1 2021 to a low of -$509000.0 in Q4 2021.
  • The 3-year median for Equity Income is -$269000.0 (2020), against an average of -$266333.3.
  • Across the five-year window, Equity Income soared 242.34% in 2021 and slumped 213.33% in 2022, its largest moves.
  • Zai Lab's Equity Income stood at -$448000.0 in 2020, then declined by 13.62% to -$509000.0 in 2021, then jumped by 56.58% to -$221000.0 in 2022.
  • The last three Equity Income figures came in at -$221000.0 (Q1 2022), -$509000.0 (Q4 2021), and -$340000.0 (Q3 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 235,807.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Zai Lab 20.15 Bn 20.05 Bn 61.30 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2022 -221,000.00
Dec 31, 2021 -509,000.00
Sep 30, 2021 -340,000.00
Jun 30, 2021 -403,000.00
Mar 31, 2021 195,000.00
Dec 31, 2020 -448,000.00
Sep 30, 2020 -265,000.00
Jun 30, 2020 -269,000.00
Mar 31, 2020 -137,000.00